Robert B. Ramsey’s and Allyson J. Singel Aldous’s recent advisory, “Recent Enforcement Action Merits Reevaluation of Compliance with Physician Supervision Requirements,” was published by Law360.

The article details why providers should reassess their compliance with requirements. The Department of Justice announced on August 27 that a New York-based diagnostic testing company agreed to a $3.57 million settlement in order to resolve allegations that the company submitted false claims for magnetic resonance imaging (MRI) services to federal health care programs.

Federal regulations require that a physician directly supervise the administration of contrast dye when used for an MRI, but the company allegedly submitted claims for the performance of MRI scans with a contrast dye without the direct supervision of a qualified physician.

Read the full article here.